US equities |
NVDA $186.64 ▲+2.78% MU $690.00 ▲+5.12% AMD $449.04 ▲+11.04% SPCX $134.27 ▲+8.62% AAPL $342.37 ▼-0.52% SNDK $835.06 ▲+3.55% MSFT $530.61 ▼-0.99% TSLA $358.22 ▲+4.23%
FinancialContent

Shanghai Fosun Pharmaceutical Group CO Ltd (OP:SFOSF)

2.140 UNCHANGED
Delayed Quote Updated: 3:04 PM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Shanghai Fosun Pharmaceutical Group CO Ltd

News headline image
Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion
From Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Via ACN Newswire
News headline image
Week In Review: Shanghai HighTide Therapeutics Files For Hong Kong IPO ↗
HighTide Therapeutics filed for an IPO on the Hong Kong Exchange. Additionally, Shanghai Fosun Pharma will partner with the International Finance Corp to build a pharmaceutical production facility and... 
Via Talk Markets
News headline image
Is Ardelyx is A Buy After Slip in Early 2022
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them 
Via MarketBeat